Back
ProShares Ultra Gold Vs. Axsome Therapeutics Industry Stock Comparison
Buy
80
UGL
ProShares Ultra Gold
Last Price:
$125.24
Seasonality Move:
1.99%
Sell
47
AXSM
Axsome Therapeutics
Last Price:
$118.50
Seasonality Move:
19.74%
Buy
80
ProShares Ultra Gold (UGL)
is a Buy
Is ProShares Ultra Gold a Buy, Sell or Hold?
-
The current ProShares Ultra Gold [UGL] share price is $125.24. The Score for UGL is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
-
UGL is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
47
Axsome Therapeutics (AXSM)
is a Sell
Is Axsome Therapeutics a Buy, Sell or Hold?
-
The current Axsome Therapeutics [AXSM] share price is $118.53. The Score for AXSM is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
AXSM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
UGL Stock Price Chart
What is ProShares Ultra Gold's stock price today?
-
The ProShares Ultra Gold share price today is $125.24Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UGL is experiencing slight buying pressure.
AXSM Stock Price Chart
What is Axsome Therapeutics's stock price today?
-
The Axsome Therapeutics share price today is $118.53The current trend is moderately bearish and AXSM is experiencing selling pressure, which indicates risk of future bearish movement.
UGL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.45 | Buy |
| Relative Strength Index (14 RSI): | 70.58 | Buy |
| Chaikin Money Flow: | 125729 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (111.62 - 121.26) | Buy |
| Bollinger Bands (100): | (94.28 - 113.52) | Buy |
AXSM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.62 | Buy |
| Relative Strength Index (14 RSI): | 44.34 | Sell |
| Chaikin Money Flow: | -342463 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (120.72 - 129.02) | Sell |
| Bollinger Bands (100): | (88.92 - 120.8) | Buy |
UGL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 121.88 | Buy |
| 20-day SMA: | 117.3 | Buy |
| 50-day SMA: | 111.83 | Buy |
| 200-day SMA: | 95.75 | Buy |
| 8-day EMA: | 121.73 | Buy |
| 20-day EMA: | 118.45 | Buy |
| 50-day EMA: | 112.52 | Buy |
| 200-day EMA: | 97.37 | Buy |
AXSM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 123.49 | Sell |
| 20-day SMA: | 123.64 | Sell |
| 50-day SMA: | 117.5 | Buy |
| 200-day SMA: | 95.28 | Buy |
| 8-day EMA: | 122.09 | Sell |
| 20-day EMA: | 122.82 | Sell |
| 50-day EMA: | 117.2 | Buy |
| 200-day EMA: | 98.97 | Buy |
ProShares Ultra Gold Earnings Growth & UGL Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Axsome Therapeutics Earnings Growth & AXSM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.59 per share, an increase next quarter of $0.25 per share, an increase this year of $1.54 per share, and an increase next year of $5.14 per share.
ProShares Ultra Gold Technical Analysis
| Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Axsome Therapeutics Technical Analysis
| Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||